Clinical Trial Update: A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

View source ↗

Summary

A clinical trial exploring c-KIT mutation as minimal residual disease (MRD) in acute myeloid leukemia. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: C-KIT Mutation | Status: RECRUITING